<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02615678</url>
  </required_header>
  <id_info>
    <org_study_id>VINJ007</org_study_id>
    <nct_id>NCT02615678</nct_id>
  </id_info>
  <brief_title>Acupuncture for CIPN in Breast Cancer Patients</brief_title>
  <official_title>Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients- A Case Series</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern California University of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern California University of Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to collect preliminary data on the effectiveness of acupuncture for
      the treatment of CIPN in breast cancer patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ideally 10 patients experiencing peripheral neuropathy due to chemotherapy from breast cancer
      treatment will be included in this study.They will receive 16 total acupuncture treatments
      over 10 weeks including various points based off of research and classical text and scalp
      acupuncture.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in perceived neuropathy as measured by EORTC CIPN-20</measure>
    <time_frame>At baseline, week 6 (treatment 12) and at week 10 (treatment 16)</time_frame>
    <description>This is a 20-item self-report multidimensional CIPN specific scale that measures sensory, motor and autonomic symptoms of a 1-4 Likert scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in perceived neuropathy as measured by Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT-GOG) Questionnaire</measure>
    <time_frame>At baseline, week 6 (treatment 12) and at week 10 (treatment 16)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in perceived neuropathy as measured by Visual Analogue Scale of Pain</measure>
    <time_frame>At baseline, week 6 (treatment 12) and at week 10 (treatment 16)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in quality of life as measured by EORTC QLQ-30</measure>
    <time_frame>At baseline, week 6 (treatment 12) and at week 10 (treatment 16)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Sensation Disorders</condition>
  <condition>Neuropathy</condition>
  <arm_group>
    <arm_group_label>Acupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acupuncture including scalp needling will be applied to selected points based on literature</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture twice a week for 6 weeks then one treatment a week for 4 weeks. Total 16 treatments in 10 weeks.</description>
    <arm_group_label>Acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Minimum of 18 years of age

          2. Currently receiving neurotoxic chemotherapy

          3. Experiencing symptoms of chemotherapy induced neuropathy for at least 1 month

          4. Have a minimum score of 3 on the VAS should have a grade II CIPN on NCICTC

          5. Willing to sign an informed consent

          6. Stable treatment for more than two months before screening

               -  Stable treatment is defined as no change in the type and dose of medications 2
                  months prior to enrollment.

               -  Once enrolled, the patients will be asked to remain on the same type and dose of
                  the medications for neuropathy

        Exclusion Criteria:

          1. Receiving any treatment to prevent neuropathy 2 weeks prior to the screening

          2. Pre-existing peripheral neuropathy due to any other cause than chemotherapy

          3. Pre-existing conditions like pregnancy, uncontrolled diabetes, hypertension,
             cardiovascular disorders, bleeding disorders, depression (BDI &gt; 21)

          4. Unwilling to follow the protocol

          5. Individuals who are receiving government disability assistance
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sivarama Vinjamury, MD, MAOM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern California University of Health Sciences, College of Eastern Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sivarama P Vinjamury, MD, MAOM</last_name>
    <phone>562 947 8755</phone>
    <phone_ext>7364</phone_ext>
    <email>sivaramavinjamury@scuhs.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jennifer M Noborikawa, BS</last_name>
    <phone>562 947 8755</phone>
    <phone_ext>452</phone_ext>
    <email>jennifernoborikawa@scuhs.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Southern California University of Health Sciences</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sivarama P Vinjamury, MD</last_name>
      <phone>562-947-8755</phone>
      <phone_ext>7364</phone_ext>
      <email>sivaramavinjamury@scuhs.edu</email>
    </contact>
    <investigator>
      <last_name>Sivarama P Vinjamury, MD, MAOM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2015</study_first_submitted>
  <study_first_submitted_qc>November 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2015</study_first_posted>
  <last_update_submitted>October 12, 2016</last_update_submitted>
  <last_update_submitted_qc>October 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southern California University of Health Sciences</investigator_affiliation>
    <investigator_full_name>Sivarama Vinjamury</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>neuropathy</keyword>
  <keyword>peripheral</keyword>
  <keyword>chemotherapy</keyword>
  <keyword>breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Sensation Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

